Patients, physicians, and progress: Lessons from the history of the National Psoriasis Foundation - 11/03/26
Doi : 10.1016/j.jaad.2026.02.063
Weston P. Lowry, BA a, Andrew Blauvelt, MD, MBA b, Mark G. Lebwohl, MD c, Jeffrey M. Cohen, MD, MPH d, e, ⁎ 
a Yale School of Medicine, New Haven, Connecticut
b Blauvelt Consulting, LLC, Annapolis, Maryland
c Department of Dermatology, Mount Sinai School of Medicine, New York, New York
d Department of Dermatology, Yale School of Medicine, New Haven, Connecticut
e Department of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut
∗ Correspondence to: Dr Jeffrey M. Cohen, MD, MPH, Department of Dermatology, Yale School of Medicine, 15 York St, New Haven, CT 06510. Department of Dermatology Yale School of Medicine 15 York St New Haven CT 06510
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Wednesday 11 March 2026
Key words : advocacy, dermatology, health equity, health policy, history, impact, medical humanities, psoriasis, stigma
| Funding sources: None. |
|
| Prior presentation: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
© 2026
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?